Sheinbaum’s response to criticism of López-Gatell’s appointment
The president of Mexico, Claudia Sheinbaum, publicly supported the appointment of Hugo López-Gatell as the country’s representative to the World Health Organization (WHO), following the criticism issued by the Independent Commission of Investigation on the pandemic. During her morning conference, the president described the objections as repetitive and linked to political positions contrary to the government.
Context of the controversy
The commission, in charge of evaluating health management during the Covid-19 emergency, expressed its concern about the appointment of López-Gatell, arguing that the position does not exist in Mexico’s official diplomatic structure. In addition, they pointed out that their investigation revealed serious omissions in the health strategy, which contributed to the country registering fourth place in the world in excess mortality, with more than 808 thousand deaths according to WHO data.
Sheinbaum, however, highlighted the professional career of the former Undersecretary of Prevention and Health Promotion: “He is a great professional who will play an excellent role in the WHO.” Likewise, she attributed the criticism to groups that, according to her, “have always been against the government” and whose opinions, she affirmed, lack new foundations.
Implications of the appointment
The debate transcends the technical and is framed in the political polarization after the pandemic. López-Gatell, a central figure in the Mexican strategy against the virus, faced questions for decisions such as the delay in the acquisition of vaccines and the limited use of diagnostic tests. Despite this, his appointment in an international role reflects the government’s commitment to consolidate its narrative on the management of the crisis.
Experts in international relations emphasize that these types of positions are usually negotiated based on bilateral agreements rather than on technical merits. However, the controversy could affect the perception of Mexico before multilateral organizations, especially on issues of transparency and accountability.
What’s next? The WHO has not officially commented on the appointment, but sources close to the process suggest that its ratification will depend on an evaluation of compatibility with the organization’s standards. Meanwhile, the Mexican government insists that the designation will strengthen its participation in global public health agendas.
Share this analysis on your social networks and discover more content on politics and public health in our specialized section.
